Abstract
A novel affinity peptide S1 (LIDHEWKENYFPLSF) was screened out via a "one bead one compound" (OBOC) approach on a microarray device. It was identified that S1 could specifically recognize and bind to vascular endothelial growth factor receptor 2 (VEGFR2), which is an angiogenesis biomarker. Moreover, S1-functionalized liposomes (S1-LS) could achieve efficient nanoscale drug delivery under the conditions of VEGFR2-overexpression in vitro and in vivo. It was demonstrated that S1-LS would be a promising VEGFR2-targeting drug delivery system.
| Original language | English |
|---|---|
| Pages (from-to) | 7087-7091 |
| Number of pages | 5 |
| Journal | Journal of Materials Chemistry B |
| Volume | 4 |
| Issue number | 44 |
| DOIs | |
| Publication status | Published - 2016 |
| Externally published | Yes |